v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   20,337,571      
Beginning balance at Dec. 31, 2023 $ 205,042 $ 2 $ 267,024 $ 67 $ (62,051)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in the January 2024 Offering, net of issuance costs (in shares)   5,307,691      
Issuance of common stock from public offering, net of issuance costs 161,333 $ 1 161,332    
Stock-based compensation expense 1,388   1,388    
Vesting of early exercised stock options $ 7   7    
Share-based compensation arrangement by share-based payment award, options, exercises in period (in shares) 0        
Issuance of common stock upon vesting of restricted stock units (in shares)   1,247      
Unrealized loss on investments $ (320)     (320)  
Net loss (13,311)       (13,311)
Ending balance at Mar. 31, 2024 $ 354,139 $ 3 429,751 (253) (75,362)
Ending balance (in shares) at Mar. 31, 2024   25,646,509      
Beginning balance (in shares) at Dec. 31, 2024 25,617,805 25,617,805      
Beginning balance at Dec. 31, 2024 $ 300,052 $ 3 435,014 296 (135,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 2,273   2,273    
Vesting of early exercised stock options $ 8   8    
Repurchase of common stock originally issued upon early exercise of stock options (in shares)   (2,600)      
Share-based compensation arrangement by share-based payment award, options, exercises in period (in shares) 68,027 68,027      
Issuance of common stock upon exercise of options $ 569   569    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,247      
Unrealized loss on investments (69)     (69)  
Unrealized loss on investments (69)        
Net loss (22,970)       (22,970)
Ending balance at Mar. 31, 2025 $ 279,863 $ 3 $ 437,864 $ 227 $ (158,231)
Ending balance (in shares) at Mar. 31, 2025 25,684,479 25,684,479